ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,528.75
      0.06%
      US Tech 100
      18,896.40
      0.00%
      Dow Jones
      40,227.59
      0.28%
      Brent Oil
      64.11
      -0.71%
      Bitcoin
      95,044.30
      0.06%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Leap Therapeutics Inc (LPTX) Quote

      Leap Therapeutics Inc

      Leap Therapeutics Inc (LPTX)

      NASDAQ
      0.3956
      0.00
      (0.00%)
      Closed April 29 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.3956
      Bid
      0.382
      Ask
      0.3995
      Volume
      -
      0.00 Day's Range 0.00
      0.2223 52 Week Range 4.79
      Market Cap
      16.322M
      Previous Close
      0.3956
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      2,342,646
      Shares Outstanding
      41,257,602
      Dividend Yield
      -
      PE Ratio
      -0.24
      Earnings Per Share (EPS)
      -1.64
      Revenue
      -
      Net Profit
      -67.79M

      About Leap Therapeutics Inc

      Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib... Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.leaptx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Leap Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LPTX. The last closing price for Leap Therapeutics was $0.40. Over the last year, Leap Therapeutics shares have traded in a share price range of $ 0.2223 to $ 4.79.

      Leap Therapeutics currently has 41,257,602 shares outstanding. The market capitalization of Leap Therapeutics is $16.32 million. Leap Therapeutics has a price to earnings ratio (PE ratio) of -0.24.

      Ask ADVFN Intelligence (AI)

      LPTX Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      April 01 2025
      LPTX (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      April 01 2025
      LPTX (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      April 01 2025
      LPTX (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      April 01 2025
      LPTX (0.00%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      March 26 2025
      LPTX (0.00%)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      Edgar (US Regulatory)
      March 26 2025
      LPTX (0.00%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.041611.75141242940.3540.40.34214038860.39435009CS
      40.099733.69381547820.29590.40.22235420700.33498458CS
      12-0.1253-24.05452102130.52090.649990.222323426460.44192789CS
      26-3.7044-90.35121951224.14.790.222314710040.81570011CS
      52-2.8644-87.86503067483.264.790.22238142281.01765402CS
      156-13.2044-97.091176470613.618.60.22236459264.43749775CS
      260-23.5044-98.344769874523.941.70.2223100633416.84997475CS

      LPTX - Frequently Asked Questions (FAQ)

      What is the current Leap Therapeutics share price?
      The current share price of Leap Therapeutics is $ 0.3956
      How many Leap Therapeutics shares are in issue?
      Leap Therapeutics has 41,257,602 shares in issue
      What is the market cap of Leap Therapeutics?
      The market capitalisation of Leap Therapeutics is USD 16.32M
      What is the 1 year trading range for Leap Therapeutics share price?
      Leap Therapeutics has traded in the range of $ 0.2223 to $ 4.79 during the past year
      What is the PE ratio of Leap Therapeutics?
      The price to earnings ratio of Leap Therapeutics is -0.24
      What is the reporting currency for Leap Therapeutics?
      Leap Therapeutics reports financial results in USD
      What is the latest annual profit for Leap Therapeutics?
      The latest annual profit of Leap Therapeutics is USD -67.79M
      What is the registered address of Leap Therapeutics?
      The registered address for Leap Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Leap Therapeutics website address?
      The website address for Leap Therapeutics is www.leaptx.com
      Which industry sector does Leap Therapeutics operate in?
      Leap Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 74.53
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.05
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9487
      (0.00%)
      		0
      AACBUArtius II Acquisition Inc
      $ 10.11
      (0.00%)
      		0
      AACBArtius II Acquisition Inc
      $ 9.95
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 74.53
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.05
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9487
      (0.00%)
      		0
      AACBUArtius II Acquisition Inc
      $ 10.11
      (0.00%)
      		0
      AACBArtius II Acquisition Inc
      $ 9.95
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 74.53
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.05
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9487
      (0.00%)
      		0
      AACBUArtius II Acquisition Inc
      $ 10.11
      (0.00%)
      		0
      AACBArtius II Acquisition Inc
      $ 9.95
      (0.00%)
      		0

      LPTX Discussion

      View Posts
      glenn1919 glenn1919 1 month ago
      LPTX...........................................................p/m
      👍️0
      Monksdream Monksdream 3 months ago
      LPTX, new 52/low
      👍️0
      glenn1919 glenn1919 3 months ago
      LPTX.......................................................bottomplay.......................................https://stockcharts.com/h-sc/ui?s=lptx&p=W&b=5&g=0&id=p86431144783
      👍️0
      tw0122 tw0122 3 months ago
      .50s seems good for an entry after the brutal dump in some .54 
      👍️0
      Deano361 Deano361 3 months ago
      Bad day today but when this gets the data results and they go to market on the drug, this is an easy 10x stock.
      👍️0
      ANTADOG ANTADOG 3 months ago
      nice volume comin' in, 3,22~~, ANT
      👍️0
      ANTADOG ANTADOG 4 months ago
      added some more, only partial fill, ANT
      👍️0
      ANTADOG ANTADOG 4 months ago
      nice chart setup, solid 3,50 break gettin' closer, ANT
      👍️0
      ANTADOG ANTADOG 4 months ago
      4's towards nxt update and jp conference almost a given, ANT
      👍️0
      ANTADOG ANTADOG 4 months ago
      touchin' 3's again, so little vol needed, nxt update should be saweet imvho ANT
      👍️0
      ANTADOG ANTADOG 4 months ago
      touched 3 again, small prelude of things to come, imosho ANT
      👍️0
      ANTADOG ANTADOG 4 months ago
      hearin' some good things comin' our way, hmm, u got to pay to play, ANT
      👍️0
      ANTADOG ANTADOG 4 months ago
      Added 2,96~~ ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,40~~ because they know... ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      accumulated a nice amount around 3 bucks, longterm, ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,35~~ ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,33~~ ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      Volume intact, ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      hooverin' above 3 bucks, ceo certainly gave them somethin' to think about, to be continued.... ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,33~~ ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,24~~ ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,19~~ ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      mm in trouble lol, ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,12~~ ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      3,10 break is close, hmm, ANT
      👍️0
      ANTADOG ANTADOG 5 months ago
      added some 2,80's, likin' the chart, ANT
      👍️0
      glenn1919 glenn1919 5 months ago
      LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      ANTADOG ANTADOG 6 months ago
      And some more 3,25's longterm, ANT
      👍️0
      ANTADOG ANTADOG 6 months ago
      added 3,70 ANT
      👍️0
      ANTADOG ANTADOG 6 months ago
      held first support, startin' to like this one more and more, gild support, fyi ANT
      👍️0
      ANTADOG ANTADOG 6 months ago
      added first support, ANT
      👍️0
      ANTADOG ANTADOG 6 months ago
      consistent buyin' often means deeper pockets like what they see or are about to find out, so they add while it's cheap, imo but we'll see soon, ANT
      👍️0
      ANTADOG ANTADOG 6 months ago
      puppy's goin' for a new 52wk high imo ANT
      👍️0
      ANTADOG ANTADOG 6 months ago
      because it's a double digitland stock, xcellent results will propel it imosho ANT
      👍️0
      joelawyer joelawyer 6 months ago
      Any clue what's driving this major upside move the last week?

      👍️0
      glenn1919 glenn1919 6 months ago
      LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 6 months ago
      LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 8 months ago
      LPTX under $3
      👍️0
      Monksdream Monksdream 9 months ago
      LPTX under $3
      👍️0
      Monksdream Monksdream 10 months ago
      LPTX under $2
      👍️0
      Monksdream Monksdream 12 months ago
      LPTX under $5
      👍️0
      glenn1919 glenn1919 1 year ago
      LPTX...................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 1 year ago
      LPTX 10Q due March 12
      👍️0
      glenn1919 glenn1919 2 years ago
      LPTX.......................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 2 years ago
      LPTX................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 2 years ago
      LPTX new 52 week low
      👍️0
      Monksdream Monksdream 2 years ago
      LPTX new 52 week low
      👍️0
      Slicky1315 Slicky1315 2 years ago
      Wow..almost a year and no one posted anything!!
      👍️0
      VivaLasVegas VivaLasVegas 3 years ago
      No one in their right mind gives 2 Sheets what some joke analyst gives for any price target

      They are Shills
      👍️0
      stockguard stockguard 3 years ago
      LPTX Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update Jan. 23
      Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Leap Therapeutics (LPTX) to $6 from $5 and keeps an Overweight rating on the shares. Following the ASCO GI update for DKN-01, Leap hosted a conference call on Friday to walk through the data and lay out potential next steps, the analyst notes. When considering potential treatment effect, Catanzaro thinks the signal in DKK1-high patients looks even more compelling. Leap believes it could initiate a small randomized Phase II as part of the current IND that could generate data in 2023, while simultaneously engaging regulatory agencies on registrational strategies. Most notably, BeiGene's (BGNE) opt-in decision for Asian rights will almost certainly be a 2022 event, and the analyst continues to believe the ASCO GI update should make that a straightforward choice.
      👍️0

      Your Recent History

      NASDAQ
      LPTX
      Leap Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads